0000070318-18-000006.txt : 20180111 0000070318-18-000006.hdr.sgml : 20180111 20180111162349 ACCESSION NUMBER: 0000070318-18-000006 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 5 CONFORMED PERIOD OF REPORT: 20180111 ITEM INFORMATION: Completion of Acquisition or Disposition of Assets ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20180111 DATE AS OF CHANGE: 20180111 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 18523851 BUSINESS ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 1445 ROSS AVENUE STREET 2: SUITE 1400 CITY: DALLAS STATE: TX ZIP: 75202 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 8-K 1 thc-20170930form8kphil.htm 8-K Document
 
 




UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 _______________
FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 _______________
Date of Report: January 11, 2018
(Date of earliest event reported)
 _______________
TENET HEALTHCARE CORPORATION
(Exact name of Registrant as specified in its charter)
 
 
 
 
 
 
Nevada
 
1-7293
 
95-2557091
(State of Incorporation)
 
(Commission File Number)
 
(IRS Employer
Identification Number)
1445 Ross Avenue, Suite 1400
Dallas, Texas 75202
(Address of principal executive offices, including zip code)
(469) 893-2200
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
 
Emerging Growth Company ¨
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ¨


 


Item 2.01.
Completion of Acquisition or Disposition of Assets.
On January 11, 2018, Tenet Healthcare Corporation (the “Company”) completed its previously announced sale of its two Philadelphia-area acute care hospitals, Hahnemann University Hospital and St. Christopher's Hospital for Children, and other related operations in Philadelphia, including physician practices (the "Divested Assets"). Affiliates of Paladin Healthcare Capital, LLC purchased the Divested Assets for a base purchase price of $170 million, which is subject to customary purchase price adjustments and includes a $17.5 million secured promissory note (the “Transaction”).
Additional information regarding the Transaction is provided in the Current Report on Form 8-K filed by the Company on September 1, 2017.
Unaudited pro forma financial information relating to the Transaction is furnished in Item 9.01 of this Current Report on Form 8-K.
Item 7.01.
Regulation FD Disclosure.
On January 11, 2018, the Company issued a press release announcing the completion of the Transaction. The press release is furnished as Exhibit 99.1 hereto.
Item 9.01.
Financial Statements and Exhibits.
(b) Pro Forma Financial Information
The Company’s Unaudited Pro Forma Condensed Consolidated Balance Sheet as of September 30, 2017 and Unaudited Pro Forma Condensed Consolidated Statement of Operations for the year ended December 31, 2016 and the nine months ended September 30, 2017 (collectively, the “Unaudited Pro Forma Financial Statements”) are furnished as Exhibit 99.2 hereto and are based on the Company’s historical consolidated results of operations and financial position, adjusted to give effect to the Transaction. The Unaudited Pro Forma Condensed Consolidated Balance Sheet as of September 30, 2017 has been prepared to present the Company’s financial condition as if the Transaction had occurred on September 30, 2017. The Unaudited Pro Forma Condensed Consolidated Statements of Operations for the year ended December 31, 2016 and the nine months ended September 30, 2017 have been prepared to present the Company’s results of operations as if the Transaction had occurred on January 1, 2016.
The Unaudited Pro Forma Financial Statements and the accompanying notes should be read together with the Company’s audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2016, and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 and Quarterly Report on Form 10-Q for the nine months ended September 30, 2017.
(d) Exhibits

SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
TENET HEALTHCARE CORPORATION
 
 
Date: January 11, 2018
By:
/s/ R. Scott Ramsey
 
  
R. Scott Ramsey
 
  
Vice President and Controller
 
  
(Principal Accounting Officer)
 
 
 
 
  
 


1
 EX-99.1 2 thc-20170930ex991phil8k.htm EXHIBIT 99.1 Exhibit

Exhibit 99.1


image0a01.jpg
newsrelease.jpg
 
Tenet Completes Sale of Philadelphia-Area Hospitals
and Related Operations

DALLAS – January 11, 2018 – Tenet Healthcare Corporation (NYSE: THC) announced today that it has completed the sale of its Philadelphia-area acute care hospitals and related operations to American Academic Health System, LLC (AAHS), an affiliate of Paladin Healthcare. Ownership and management of the hospitals and related operations will transfer to AAHS on Thursday, January 11, 2018 at 11:59 pm ET.
Tenet and Paladin Healthcare previously announced the transaction on September 1, 2017. The facilities included in the sale are Hahnemann University Hospital, St. Christopher’s Hospital for Children and other hospital-affiliated entities, including physician practices. Tenet received net pre-tax proceeds from the transaction of approximately $152.5 million in cash and a secured promissory note for $17.5 million.
About Tenet Healthcare
Tenet Healthcare Corporation is a diversified healthcare services company with 125,000 employees united around a common mission: to help people live happier, healthier lives. Through its subsidiaries, partnerships and joint ventures, including United Surgical Partners International, the Company operates general acute care and specialty hospitals, ambulatory surgery centers, urgent care centers and other outpatient facilities in the United States and the United Kingdom. Tenet’s Conifer Health Solutions subsidiary provides technology-enabled performance improvement and health management solutions to hospitals, health systems, integrated delivery networks, physician groups, self-insured organizations and health plans. For more information, please visit www.tenethealth.com.

The terms "THC", "Tenet Healthcare Corporation", "the company", "we", "us" or "our" refer to Tenet Healthcare Corporation or one or more of its subsidiaries or affiliates as applicable.

###

Investor Contact:
Brendan Strong
469-893-6992
investorrelations@tenethealth.com
Media Contact:
Daniel Waldmann
469-893-2640
mediarelations@tenethealth.com


Tenet uses its Company website to provide important information to investors about the Company including the posting of important announcements regarding financial performance and corporate development.



 EX-99.2 3 thc-20170930ex992phil8k.htm EXHIBIT 99.2 Exhibit
Exhibit 99.2

Unaudited Pro Forma Financial Statements
The following Unaudited Pro Forma Financial Statements are based on the Company’s historical consolidated results of operations and financial position, adjusted to give effect to the Transaction, as defined in Item 2.01 of this Form 8-K, as if it had been completed on September 30, 2017 with respect to the pro forma condensed consolidated balance sheet and as of January 1, 2016 with respect to the pro forma condensed consolidated statements of operations.
The Unaudited Pro Forma Financial Statements and the accompanying notes should be read together with the Company’s audited consolidated financial statements and accompanying notes as of and for the year ended December 31, 2016, and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2016 (“Annual Report”) and its unaudited condensed consolidated financial statements and accompanying notes as of and for the nine months ended September 30, 2017 and Management’s Discussion and Analysis of Financial Condition and Results of Operations included in the Company's Quarterly Report on Form 10-Q ("Quarterly Report") for the nine months ended September 30, 2017. The Unaudited Pro Forma Financial Statements may differ materially from the future financial position or results of operations due to a number of factors described in “Risk Factors” under Item 1A of Part 1 of our Annual Report and “Forward-Looking Statements” under Item 1 of Part 1 of our Annual Report.


1

Tenet Healthcare Corporation
Unaudited Pro Forma Condensed Consolidated Balance Sheet
September 30, 2017
(Dollars in millions)
 
Historical
 
Pro Forma Adjustments
 
Pro Forma
ASSETS
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
429

 
$
153

 
(a)
 
$
582

Accounts receivable, less allowance for doubtful accounts
 
2,567

 
 
 
 
 
2,567

Inventories of supplies, at cost
 
297

 
 
 
 
 
297

Income tax receivable
 
14

 
 
 
 
 
14

Assets held for sale
 
842

 
(222
)
 
(a)
 
620

Other current assets
 
1,160

 
 
 
 
 
1,160

Total current assets
 
5,309

 
(69
)
 
 
 
5,240

Investments and other assets
 
1,253

 
17

 
(a)
 
1,270

Deferred income taxes
 
783

 
—

 
(a)
 
783

Property and equipment, at cost, less accumulated depreciation and amortization
 
7,077

 


 
 
 
7,077

Goodwill
 
7,022

 
 
 
 
 
7,022

Other intangible assets, at cost, less accumulated amortization
 
1,764

 
 
 
 
 
1,764

Total assets 
 
$
23,208

 
$
(52
)
 
 
 
$
23,156

LIABILITIES AND EQUITY
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
Current portion of long-term debt
 
$
140

 
 
 
 
 
$
140

Accounts payable
 
1,100

 
 
 
 
 
1,100

Accrued compensation and benefits
 
800

 
 
 
 
 
800

Professional and general liability reserves
 
210

 
 
 
 
 
210

Accrued interest payable
 
336

 
 
 
 
 
336

Liabilities held for sale
 
407

 
(52
)
 
(a)
 
355

Other current liabilities
 
1,146

 
 
 
 
 
1,146

Total current liabilities
 
4,139

 
(52
)
 
 
 
4,087

Long-term debt, net of current portion
 
14,741

 
 
 
 
 
14,741

Professional and general liability reserves
 
617

 
 
 
 
 
617

Defined benefit plan obligations
 
596

 
 
 
 
 
596

Other long-term liabilities
 
604

 
 
 
 
 
604

Total liabilities
 
20,697

 
(52
)
 
 
 
20,645

Commitments and contingencies
 
 
 
 
 
 
 
 
Redeemable noncontrolling interests in equity of consolidated subsidiaries
 
1,816

 
 
 
 
 
1,816

Equity:
 
 
 
 
 
 
 
 
Shareholders’ equity:
 
 
 
 
 
 
 
 
Common stock
 
7

 
 
 
 
 
7

Additional paid-in capital
 
4,835

 
 
 
 
 
4,835

Accumulated other comprehensive loss
 
(238
)
 
 
 
 
 
(238
)
Accumulated deficit
 
(2,161
)
 
—

 
(a)
 
(2,161
)
Common stock in treasury, at cost
 
(2,419
)
 
 
 
 
 
(2,419
)
Total shareholders’ equity
 
24

 
—

 
 
 
24

Noncontrolling interests
 
671

 
 
 
 
 
671

Total equity
 
695

 
—

 
 
 
695

Total liabilities and equity
 
$
23,208

 
$
(52
)
 
 
 
$
23,156




2

Notes to Unaudited Pro Forma
Condensed Consolidated Balance Sheet

(a)
Records the initial base purchase price cash and note receivable proceeds from the sale of the Philadelphia-area hospitals and related facilities, derecognition of the related assets and liabilities held for sale, and the related after-tax loss on sale, using an effective rate of 37%, which includes the federal statutory rate of 35% and the applicable state tax rate that were in effect as of September 30, 2017.
 
 
 
 
 
 
 
 
 
 
 
 


3

Tenet Healthcare Corporation
Unaudited Pro Forma Condensed Consolidated Statement of Operations
For the Year Ended December 31, 2016

(Dollars in millions except per share amounts)
 
Historical
 
Pro Forma Adjustments
 
Pro Forma
 
 
 
 
 
 
 
 
 
Net operating revenues:
 
 
 
 
 
 
 
 
Net operating revenues before provision for doubtful accounts
 
$
21,070

 
$
(813
)
 
(a)
 
$
20,257

Less: Provision for doubtful accounts
 
1,449

 
(26
)
 
(a)
 
1,423

Net operating revenues 
 
19,621

 
(787
)
 
 
 
18,834

Equity in earnings of unconsolidated affiliates
 
131

 
—

 
 
 
131

Operating expenses:
 
 
 
 
 
 
 
 
Salaries, wages and benefits
 
9,356

 
(391
)
 
(a)
 
8,965

Supplies
 
3,124

 
(114
)
 
(a)
 
3,010

Other operating expenses, net
 
4,891

 
(302
)
 
(a)
 
4,589

Electronic health record incentives
 
(32
)
 
1

 
(a)
 
(31
)
Depreciation and amortization
 
850

 
(18
)
 
(a)
 
832

Impairment and restructuring charges, and acquisition-related costs
 
202

 
(38
)
 
(a)
 
164

Litigation and investigation costs
 
293

 
—

 
 
 
293

Gains on sales, consolidation and deconsolidation of facilities
 
(151
)
 
—

 
 
 
(151
)
Operating income
 
1,219

 
75

 
 
 
1,294

Interest expense
 
(979
)
 
—

 
 
 
(979
)
Other non-operating income (expense), net
 
8

 
—

 
 
 
8

Net income from continuing operations, before income taxes
 
248

 
75

 
 
 
323

Income tax benefit (expense)
 
(67
)
 
(27
)
 
(b)
 
(94
)
Net income from continuing operations 
 
181

 
48

 
 
 
229

Less: Net income attributable to noncontrolling interests
 
368

 
1

 
(a)
 
369

Net loss attributable to Tenet Healthcare Corporation common shareholders 
 
$
(187
)
 
$
47

 
 
 
$
(140
)
Loss per share attributable to Tenet Healthcare Corporation common shareholders:
 
 
 
 
 
 
 
 
Basic
 
$
(1.88
)
 
 
 
 
 
$
(1.41
)
Diluted
 
$
(1.88
)
 
 
 
 
 
$
(1.41
)
Weighted average shares and dilutive securities outstanding (in thousands):
 
 
 
 
 
 
 
 
Basic
 
99,321

 
 
 
 
 
99,321

Diluted
 
99,321

 
 
 
 
 
99,321




4

Tenet Healthcare Corporation
Unaudited Pro Forma Condensed Consolidated Statement of Operations
For the Nine Months Ended September 30, 2017

(Dollars in millions except per share amounts)
 
Historical
 
Pro Forma Adjustments
 
Pro Forma
 
 
 
 
 
 
 
 
 
Net operating revenues:
 
 
 
 
 
 
 
 
Net operating revenues before provision for doubtful accounts
 
$
15,310

 
$
(617
)
 
(a)
 
$
14,693

Less: Provision for doubtful accounts
 
1,109

 
(13
)
 
(a)
 
1,096

Net operating revenues 
 
14,201

 
(604
)
 
 
 
13,597

Equity in earnings of unconsolidated affiliates
 
95

 
—

 
 
 
95

Operating expenses:
 
 
 
 
 
 
 
 
Salaries, wages and benefits
 
6,990

 
(289
)
 
(a)
 
6,701

Supplies
 
2,285

 
(79
)
 
(a)
 
2,206

Other operating expenses, net
 
3,466

 
(231
)
 
(a)
 
3,235

Electronic health record incentives
 
(8
)
 
—

 
 
 
(8
)
Depreciation and amortization
 
662

 
(16
)
 
(a)
 
646

Impairment and restructuring charges, and acquisition-related costs
 
403

 
(235
)
 
(a)
 
168

Litigation and investigation costs
 
12

 
—

 
 
 
12

Gains on sales, consolidation and deconsolidation of facilities
 
(142
)
 
—

 
 
 
(142
)
Operating income
 
628

 
246

 
 
 
874

Interest expense
 
(775
)
 
1

 
(a)
 
(774
)
Other non-operating income (expense), net
 
(14
)
 
—

 
 
 
(14
)
Loss from early extinguishment of debt
 
(164
)
 
—

 
 
 
(164
)
Net income from continuing operations, before income taxes
 
(325
)
 
247

 
 
 
(78
)
Income tax benefit (expense)
 
105

 
(86
)
 
(b)
 
19

Net income from continuing operations
 
(220
)
 
161

 
 
 
(59
)
Less: Net income attributable to noncontrolling interests
 
254

 
—

 
 
 
254

Net loss attributable to Tenet Healthcare Corporation common shareholders
 
$
(474
)
 
$
161

 
 
 
$
(313
)
Loss per share attributable to Tenet Healthcare Corporation common shareholders:
 
 
 
 
 
 
 
 
Basic
 
$
(4.72
)
 
 
 
 
 
$
(3.12
)
Diluted
 
$
(4.72
)
 
 
 
 
 
$
(3.12
)
Weighted average shares and dilutive securities outstanding (in thousands):
 
 
 
 
 
 
 
 
Basic
 
100,475

 
 
 
 
 
100,475

Diluted
 
100,475

 
 
 
 
 
100,475




5


Notes to Unaudited Pro Forma
Condensed Consolidated Statement of Operations

(a)
Eliminates the historical revenue and operating expenses of the divested Philadelphia hospitals and related facilities.
 
 
(b)
Reflects the applicable income tax effects of the pro forma adjustments in this column at an effective tax rate of 37%, which includes the federal statutory rate of 35% and the applicable state tax rate that were in effect during the period presented, adjusted for the impact of nondeductible goodwill.
 
 
 
 



6
 GRAPHIC 4 image0a01.jpg begin 644 image0a01.jpg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newsrelease.jpg begin 644 newsrelease.jpg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end